Randomized, Double-Blind, Placebo-Controlled, Parallell-Group, 12-Month Trial of Leuco-methythionium bis(hydromethanesulfonate) in Subjects With Mild to Moderate Alzheimer's Disease
What is the purpose of this trial?
The purpose of this study is to determine the safety and efficacy of Leuco-methylthionium bis(hydromethanesulfonate) in the treatment of subjects with mild to moderate Alzheimer's Disease
- Up to 89 Years
- TauRx Therapeutics, Ltd
- 12/2012 - 3/15
- Last Updated:
- Study HIC#: